About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Researchers at the University of Gothenburg have uncovered a critical mechanism that may pave the way for innovative ...

Living kidney donors with discordant kidney function measures had lower eGFR after donation and a higher risk for eGFR counts ...

Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

In a remarkable display of market confidence, VATE stock has surged to a 52-week high, with shares trading at an impressive $13.31, representing a dramatic 309% increase from its 52-week low of $3.25.

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Kidney health is essential for your overall health and one of the best ways to measure it is through your creatinine levels ...

Our study highlights the difficulty in diagnosing acute and chronic kidney disease, and the need for more accurate methods ... glomerular filtration rate (GFR) <60 mL/min/1.73 m 2 or decrease in GFR ...

Objective To systematically identify and describe self-management interventions for adult patients with chronic kidney disease (CKD). Setting Community-based. Participants Adults with CKD stages 1–5 ...